Lung cancer risk associated with thr495pro polymorphism of GHR in chines population

Japanese Journal of Clinical Oncology

Volumn 38, Issue 4, 2008, Pages 308-316

  Cao, Guochun ^a,b   Lu, Hongna ^a   Feng, Jifeng ^b   Shu, Jian ^c   Zheng, Datong ^a,d   Hou, Yayi ^a  

^a NANJING UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

^d THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

GHR; Lung cancer; MDR; Molecular epidemiology; Thr495Pro polymorphism

Indexed keywords

GROWTH HORMONE RECEPTOR; PROLINE; THREONINE;

ACCURACY; ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROLINE; RECEPTORS, SOMATOTROPIN; RISK ASSESSMENT; RISK FACTORS; SMOKING; THREONINE;

EID: 42549154929     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn007     Document Type: Article

References (26)

1. Lee GY, Jang JS, Lee SY, Jeon HS, Kim KM, Choi JE, et al. XPC polymorphisms and lung cancer risk. Int J Cancer 2005;115: 807-13.
2. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000;18:2309-15.
3. Mohrenweiser HW, Jones IM. Variation in DNA repair is a factor in cancer susceptibility: A paradigm for the promise and perils of individuals and population risk estimation? Mutat Res 1998; 400:15-24.
4. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
5. Wang X, He K, Gerhart M, Jiang J, Paxton RJ, Menon RK, et al. Reduced proteolysis of rabbit growth hormone (GH) receptor substituted with mouse GH receptor cleavage site. Mol Endocrinol 2003;17(10):1931-43.
6. Wagner K, Hemminki K, Grzybowska E, Bermejo JL, Butkiewicz D, Pamula J, et al. Polymorphisms in the growth hormone receptor: A case-control study in breast cancer. Int J Cancer 2006;118(11):2903-6.
7. Kaulsay KK, Zhu T, Bennett W, Lee KO, Lobie PE. The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor. Endocrinology 2001;142:767-77.
8. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000;21:215-44.
9. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A, et al. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000;88:828-32.
10. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999;91:620-5.
11. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis. J Natl Cancer Inst 1999;91:151-6.
12. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, et al. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 1998;279:563-6.
13. Rudd MF, Webb EL, Matakidou A, Sellick GS, Williams RD, Bridle H, et al., GELCAPS Consortium Variants in the GH-IGF axis confer susceptibility to lung cancer. Genome Res 2006;16(6):693-701.
14. McKay JD, Kaaks R, Johansson M, Biessy C, Wiklund F, Bälter K, et al. Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16(1):169-73.
15. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goossens M, Amselem S. Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 2000;275: 18664-9.
16. Stallings-Mann ML, Ludwiczak RL, Klinger KW, Rottman F. Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism. Proc Natl Acad Sci USA 1996;93:12394-9.
17. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995;59:97-105.
18. Wallenstein S, Hodge SE, Weston A. Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 1998;15:173-81.
19. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69(1):138-47.
20. Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003;24(2):150-7.
21. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003;19(3):376-82.
22. Coffey CS, Hebert PR, Ritchie MD, Krumholz HM, Gaziano JM, Ridker PM, et al. An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: The importance of model validation. BMC Bioinform 2004;5:49.
23. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 2004;36:720-4.
24. Doll R, Peto R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66(6):1191-308.
25. Morabia A, Wynder EL. Cigarette smoking and lung cancer cell types. Cancer 1991;68(9):2074-8.
26. Schoenberg JB, Wilcox HB, Mason TJ, Bill J, Stemhagen A. Variation in smoking-related lung cancer risk among New Jersey women. Am J Epidemiol 1989;130(4):688-95.